Camilla, who was shortlisted as a finalist for Innovator of the Year at the 2025 Digital Women Awards, says her mission has always been to give first-opinion vets the tools and confidence to get the most from ultrasound in everyday practice – and the new tool is a big step forward in that vision.
The tool:
Camilla says the final report is fully editable, but much of the “heavy lifting” is done — saving time, reducing second-guessing, and producing reports that are more useful for colleagues, clients, and patient care.
https://www.fovu.co.uk/
https://www.fovu.co.uk/fovu-report-video
The research surveyed 647 UK-based employees of CVS’ companion animal practices between December 2022 and March 2023.
Participants included veterinary surgeons, veterinary nurses, patient care assistants, receptionists and administrative staff.
The survey explored injury prevalence, the context in which injuries occurred, and the behaviours of injured persons.
Over 77% of respondents reported experiencing a work-related injury at any point during their career.
Injury rates were highest among veterinary surgeons (58.3% injured in the last year) and veterinary nurses (60.2%).
Most injuries occurred in clinical areas such as consulting rooms, prep areas, and wards.
Unsurprisingly, animal-related injuries were the most common, particularly involving cats and dogs during restraint or clinical procedures.
However, a significant number of injuries to receptionists and administrators also involved restraining animals, highlighting the multi-faceted nature of these roles.
Clinical examinations were the most common activity occurring at the point of injury for vets.
Another common situation for vet and nurse injuries were when animals were recovering from anaesthesia.
Nearly 10% of all injuries in the study were needlestick-related, often linked to handling practices.
The study also uncovered a strong culture of presenteeism, where staff continue to work despite injury, often due to fear of letting colleagues down or their dedication to their patients.
Between 16 and 23% of staff attended hospital for their most recent injury and more than 25% needed more than seven days to recover from their injury.
Despite this fewer than 14% of respondents took more than seven days off work.
When outlining reasons for the injury occurring, particularly during animal restraint, participants attributed their injury on a colleague’s actions or a miscommunication.
Around half of respondents said they would not change their behaviour if faced with the same situation again, even after being injured.
Thematic analysis revealed a weak safety culture, particularly among veterinary surgeons, who were the least likely to report injuries.
Many viewed injuries as inevitable or not worth reporting.
Dr. Tulloch said: “This research highlights the everyday risks faced by veterinary professionals, particularly those in companion animal practice.
"While many injuries are accepted as part of the job, our findings show that many are preventable with the right training, equipment, and safety culture.
“Our study calls for a shift toward a positive safety culture, built on open reporting, shared responsibility, and reflective learning.
"It highlights the need for targeted interventions in high-risk areas such as animal restraint, anaesthetic recovery, and sharps handling.
“Achieving this safety culture shift requires strong organisational leadership across the profession and a commitment to fostering a work environment where all staff feel they speak openly and take accountability for workplace safety.”
Imogen Schofield, Director of Clinical Research at CVS, said: "As a result of the research, CVS has set up a working group looking at how we can reduce the top causes of accidents and improve the under-reporting figure.
"We are also looking at how we can use information held within our practice management system to understand more fully rates of accident per consult numbers or numbers of needlestick injuries per injections given.”
CVS says the full findings of the research will be shared with the wider veterinary community in due course, to support industry-wide improvements in occupational health and safety.
The research took the form of a voluntary survey asking those voluntarily leaving their registers to explain why.
643 veterinary surgeons in the survey were leaving the UK-practising category, mostly to be close to family or friends, whilst 306 were leaving the Register altogether.
The next most common reason for veterinary surgeons leaving the UK-practising category was retirement (23%), most of whom were retiring before the state pension age.
Of those retiring before state pension age, one-third cited health and wellbeing reasons.
Vets were asked to explain in greater detail their decision to leave either the UK-practising category or the Register altogether in free text boxes at the end of the survey.
Those leaving the UK-practising category were most likely to mention health and wellbeing issues, closely followed by issues in the profession such as the demands of working in clinical practice.
A third of the comments left by those leaving the Register altogether mentioned issues to do with RCVS regulation, such as cost and continuing professional development (CPD).
Vicki Bolton, RCVS Research Manager, said: “This data is invaluable to us in understanding the reasons why people choose to leave the RCVS Registers.
“The reasons given don’t always make for easy reading, especially when they are to do with dissatisfaction over the direction the professions are taking, physical and mental health and wellbeing, financial pressures and concerns about regulation and its costs.
“However, it is important to remember that, overall, relatively few veterinary surgeons and veterinary nurses leave the professions each year.
"There is no mass exodus from the professions and the numbers joining the UK Register annually well exceed those leaving, as demonstrated by consistent year-on-year increases in the number of veterinary surgeon and veterinary nurse registrants.
“That being said, these results will form an invaluable part of our ongoing work on veterinary workforce and gives the RCVS food for thought about how and where we can better support veterinary surgeons and veterinary nurses to stay in the professions rather than leave prematurely.”
https://www.rcvs.org.uk/news-and-views/our-consultations/exit-survey-2022-2024/
Photo: AI generated.
Animalcare says that failing to attend to dental care at home results in 9 out of 10 dogs needing advanced dental treatment or procedures at the vets.
Plaqtiv dental sticks are designed to complement dental care by helping reduce plaque and tartar build-up and freshen breath in a tasty, once-daily treat.
Animalcare says the five-point star shape helps target hard-to-reach areas and the length and width of each stick means that teeth can be reached front to back and top to bottom during chewing.
In addition, the active algae ingredient contained within each stick is scientifically proven to help prevent plaque and the inclusion of zinc helps freshen breath.
Rachel Smithson, Country Manager at Animalcare, said: "The addition of the Dental Sticks to the Plaqtiv+ range gives practices and pet owners another option for maintaining oral health.
"With multiple formats now available, the Plaqtiv+ range caters to individual pet needs and owner preferences while supporting long-term home dental healthcare."
https://dental.pet
The CMA proposed that veterinary practices should be compelled to:
Most of these, along with the CMA's support for reform of the Veterinary Surgeons Act, have been welcomed not just by the BVA, but by the RCVS and the BVNA which also issued their responses on Friday.
The big sticking points, however, are the proposal that veterinary practices should cap prescription fees at £16, and that all practices should inform clients that they may buy medicines cheaper online.
The BVA argued that the proposed prescription price cap would be unlikely to reduce costs, and that 65% of vets who took part in its Voice of the Profession Survey said it would risk practice viability.
The proposal that vets should tell clients they can buy medicines cheaper online was more controversial, because of course two of the largest veterinary pharmacies are owned by corporate groups, and it is hard to think of any other area of business where small companies are legally required to direct customers to their corporate competitors.
BVA President Dr. Rob Williams MRCVS (pictured) said: “The measures outlined in the CMA’s provisional decision report are much more measured and proportionate compared to earlier proposals and that clearly shows they have listened to our concerns.
"As vets, we welcome the measures that increase transparency and help us to better support our clients.
"However, it’s vital that the CMA gets the detail right or it risks unintended negative consequences.
“BVA particularly welcomes the CMA backing our calls for reform of the outdated Veterinary Surgeons Act, including the need for practice regulation.
"Vets have been pressing for reform of this woefully outdated legislation for many years, and reform will go a long way to addressing many of the concerns raised throughout the CMA investigation and will help build trust with our clients.
“We do, however, have serious concerns about the medicines proposals – it is simply unreasonable to expect vet practices to actively promote online pharmacies, which are in direct competition for customers and some of which are run by large veterinary groups.
"In addition, the proposed £16 price cap for prescriptions will be ineffective and is unlikely to lead to lower vet bills for consumers.”
https://www.bva.co.uk/media/6641/bva-bsava-bvna-spvs-vmg-joint-response-to-cma-provisional-decision-report-final.pdf
The new guidelines are freely available in the Journal of Feline Medicine and Surgery (JFMS), along with accompanying guides for vet nurses and cat carers.
Samantha Taylor, iCatCare Veterinary Specialist Consultant and co-author and panel chair for the guidelines said: “There have been significant developments in the treatment of feline diabetes mellitus since the publication of the 2015 ISFM diabetes guidelines.
"Experts in the disease from the USA, Netherlands, UK, Australia and Italy have collaborated on a much-needed update and the resulting 2025 iCatCare consensus guidelines are an essential information resource for vets diagnosing and treating diabetes mellitus in cats.”
https://internationalcatcare.cmail20.com/t/i-l-znwll-tykyklax-k/
Mike Ellinger, Business Unit Director, UK Diagnostics at Zoetis said: “VPG’s national reputation for quality and deep expertise strengthens our ability to innovate and expand our diagnostic offerings to better serve the veterinary community in the UK and Ireland.
“Our shared commitment to service excellence means we can continue to support veterinary customers seamlessly from day one.
"This acquisition strengthens our ability to innovate and expand our diagnostic offerings to better serve the veterinary community’s point-of-care and reference lab needs in the UK and Ireland.”
https://thevpg.co.uk
The installation is a collaboration between Vet Sustain and IVC Evidensia, supported by MSD Animal Health.
Laura Gelder-Robertson, CEO of Vet Sustain, said: “We want to show the best of what already exists within veterinary sustainability, to bring to life the business benefits for veterinary teams in a really hands-on, practical way that people can touch and feel and relate back to their everyday practice.
"This is a really positive news story where by sharing knowledge and collaborating across the profession, we can continually improve the health and wellbeing of animals, people, the environment and business.”
https://vetsustain.org
The awards are an opportunity to acknowledged unsung heroes within the veterinary profession, celebrating those who have made significant contributions to veterinary science, research, clinical practice, education and the welfare of small animals.
The award categories are:
Nominations are welcome from both BSAVA members and non-members.
Nominations will close on 9th January 2026 and the winners will be announced in February 2026.
Adam Gow, BSAVA Honorary Secretary said: “Each year, we’re proud to shine a spotlight on individuals who have truly made a difference in our profession.
"Nominating a colleague is a meaningful way to show appreciation and celebrate the impact they’ve had, so we encourage everyone to get involved and put forward those who inspire them.”
https://www.bsava.com/awards
The bundle includes:
To be in with a chance of winning, take the Lec Medical voucher from the Vet Show voucher book to stand T64.
https://www.lec-medical.co.uk/en-gb
Brainchild of Tom Towey MRCVS, an ECC clinician, the new service allows vets to upload case details, including the level of urgency, and then browse the referral centres that can meet the need, listed by the distance to the practice or to the client and the level of expertise available (eg. Specialist / Advanced Veterinary Practitioner).
You then select the ones that look interesting, press submit, and the request is sent on your behalf.
The referral practices you've contacted can then reply with their estimate for the procedure and details of when they can see the case.
The owner is notified about each new estimate and can decide which to accept.
When they do, the referral clinic then calls the owner to make an appointment.
Tom highlights part of the Competition and Markets Authority provisional report which says:
"10.16: Our provisional view is that, in a well-functioning market, where multiple referral providers are available and clinically appropriate, we would expect pet owners to be made aware that they can choose a referral provider and to be able to access information about those providers including the nature of the treatment, the skills and experience of the referral vet, the availability of appointments, and, in many cases, the likely cost."
Tom's new service seems to fit the bill precisely.
www.rapidreferrals.co.uk
The BVA released the result of the survey, which had 1,332 respondents, ahead of the BVA Congress at the London Vet Show, where the hot topic session: "Your voice, your future: Shaping the Veterinary Surgeons Act for every professional" will explore what reform of the VSA could look like, the impact it could have on how vet professionals deliver services and the effect changes could deliver for clients and their animals.
The session is being hosted by BVA Junior Vice President Gwen Rees who will be joined by special guests Natasha Widdowson, Head of Veterinary Policy at the Department for Environment, Food and Rural Affairs (Defra), RCVS President Tim Parkin, Samantha Butler Davis from VetsforPets and Liz Mullineaux, BVA Senior Vice President.
The BVA says Defra plans a public consultation on draft legislation later this year, making this an opportunity for veterinary professionals to engage and ask questions about what the proposed changes are likely to mean in practice.
British Veterinary Association President Rob Williams (pictured) said: “Many of the issues raised by the Competition and Markets Authority investigation, including the need for practice regulation, would be addressed through reform of the Veterinary Surgeons Act.
"And after years of BVA campaigning we’re finally taking a step forward as Defra prepares to consult on draft legislation.
"It’s therefore vital for the professions to grasp this opportunity and get behind reform.
"Our session at BVA Congress is a chance to ask questions, understand the potential changes and help shape future veterinary legislation.”
https://london.vetshow.com
This, says the company, highlights a missed opportunity for earlier cancer detection, which in turn limits the ability of veterinary teams to improve medical outcomes for their patients.
243 veterinary professionals took part in the survey, most of whom HT Vista says were general practitioners.
On average, they reported seeing 13.5 dermal and subcutaneous masses per vet per week, less than six of which lead to a diagnosis.
HT Vista says around 15% of these lumps will be malignant.
Veterinary oncologist Gillian Dank said: “Every week, thousands of dogs leave practices with undiagnosed masses.
"While many are benign, others are malignant, and delaying diagnosis can mean lost treatment opportunities and poorer prognoses.”
The number one reason why respondents said they don't test more widely is the assumption that a mass is benign by its gross characteristics, followed by owner concerns around cost, time constraints during consultations, and limited access to in-house cytology.
Vista HT Chief Commercial Officer Asher Fink and Managing Director Liron Levy-Hirsch will be presenting “20 dogs in your waiting room with lumps and bumps – how do you spot the 3 with cancer?" at the London Vet Show on 20th November from 1–1:50pm in Exhibitor Showcase Theatre 2
https://info.ht-vet.com/lump-and-bump-survey-results
https://www.cliniciansbrief.com/continuing-education/syllabus/lesson/cracking-code-lumps-bumps-fast-efficient-diagnosis-everyday-practice
https://london.vetshow.com/conference-programme-2025/session-title-coming-soon-38
Photo: www.depositphotos.com
The procedure, called transcatheter edge-to-edge repair (TEER), is a minimally invasive alternative to open heart surgery.
TEER is performed on a beating heart using a specially designed “V-Clamp” device which brings the mitral valve leaflets together, reducing the severity of mitral regurgitation.
The procedure is guided by real-time 3D echocardiography and performed via a small thoracotomy, typically 6–8 cm in length.
CVS, which owns Bristol Vet Specialists, says dogs undergoing TEER generally experience a rapid recovery, with most discharged within 48 hours and minimal need for intensive care.
The company says that once heart failure is diagnosed, the average survival time is between nine and 12 months, but that after TEER surgery, 95% of dogs are discharged successfully, and 85% survive for two years post surgery.
The procedure costs £12,000.
http://www.bristolvetspecialists.co.uk
Miss Davies faced four charges:
Miss Davies made no admissions to any of the charges.
Miss Davies wrote to the College prior to the hearing stating that she would not be attending and she was not represented.
The Committee found all charges bar one proved.
Charge 1a, relating to the anaesthesia increase, was found not proved due to lack of evidence.
In deciding on whether the proven facts amounted to serious professional misconduct, the Committee took into account the aggravating factor that all charges caused risk of injury to an animal or human.
There were no mitigating factors.
The Committee found that Miss Davies’ conduct indicated an unwillingness and inability to act according to the veterinary surgeons’ instructions/directions.
It noted that Miss Davies acted on at least seven occasions contrary to the instructions given or without seeking direction or authorisation, despite her position within the surgical team.
It also found that Miss Davies had breached multiple areas of the Code of Professional Conduct for Veterinary Nurses, including the Code obligations that veterinary nurses must make animal health and welfare their first consideration when attending to animals and that veterinary nurses must communicate with veterinary surgeons and each other to ensure the health and welfare of the animal or group of animals.
It therefore found that, with the exception of administering intermittent positive-pressure ventilation without direction or authorisation, the remaining proved facts amounted to serious professional misconduct.
The Committee then went on to consider the most appropriate and proportionate sanction.
In doing so, it took into account aggravating and mitigating factors.
Aggravating factors included that the conduct was sustained over a period of approximately eight months and took place during four separate surgical procedures, and that Miss Davies posed a risk to animals on each occasion.
The Committee considered that there were a number of mitigating factors including the fact that Miss Davies had been on the Register of Veterinary Nurses since 17 January 2006 with no previous disciplinary findings against her, positive testimonials from a colleague working with Miss Davies at the time of the incidents, and the fact that Miss Davies had expressed some remorse in a letter regarding her conduct in relation to charges 3 and 4.
Colin Childs, chairing the Committee and speaking on its behalf, said: “The Committee found that the charges represented a serious departure from the Code of Professional Conduct for Veterinary Nurses and also that there was evidence that Miss Davies had put her own interests before the health and welfare of animals either by not following the instructions of veterinary surgeons or by acting unilaterally, in relation to the administration of medicines or the placement of a catheter or feeding tube during four surgical procedures.
“Since the Committee could not assess Miss Davies’ future risk or her insight in her absence, it therefore decided that removal was the only proportionate sanction because any other sanction would not protect animals or the public in the future without those matters having been adequately assessed.
Such a sanction also met the wider public interest.
“The Committee therefore directed that the Registrar remove Miss Davies from the Register of Veterinary Nurses.”
www.rcvs.org.uk/disciplinary
Vikaly is indicated for the nutritional and medical management of chronic kidney disease in adult and senior cats with proteinuria, from IRIS stage 2.
The new diet delivers the same therapeutic dosage as benazepril tablets (0.5–1 mg/kg bodyweight/day).
Nutrition-wise, Vikaly is low phosphorus (0.5% as fed), has reduced protein (30% as fed), contains omega-3 fatty acids (1.2%, including 0.6% EPA & DHA) and offers high metabolisable energy (416 kcal/100g).
Virbac highlights data showing that CKD remains the leading cause of mortality in cats over five years old and affects up to 40% of feline patients over the age of ten1,2.
The company says administering daily treatment is recognised as a major issue for CKD cat owners with 45% of owners not administering treatment daily as they should and 51% of owners citing administration difficulties as the reason why3.
This new product eliminates the need to administer medication separately, which could completely transform treatment compliance, removing the risk of missed doses and reducing stress for both cats and their owners.
Virbac says that due to the pharmacokinetic profile of benazepril, which is incorporated into the kibble, at an equivalent dose Vikaly displays greater ACE inhibition than benazepril tablets4.
The rate of food consumption also does not affect plasma Benazeprilat levels, ensuring consistent treatment efficacy regardless of the cat’s feeding behaviour5.
Virbac says that in practice, this means that even if the cat being treated consumes less than 50% of their daily ration, efficacy is maintained with ACE activity similar to that of benazepril tablets.
Benazepril has a wide therapeutic margin, tolerated to 20x the minimum effective dose (10mg/kg) for 52 weeks, with the first signs of toxicity being reduced erythrocytes counts & ovary/oviduct weights6.
Virbac says that with Vikaly, these levels cannot be reached because the active ingredient is contained in food, which would require a cat to consume more than 10 times their daily ration.
Vikaly is presented in a 1.5kg bag, which equates to a 30 day supply for a 4.5kg cat with normal bodyweight.
It can be fed alongside wet food, providing that the cat consumes at least 50% of their daily ration before being given the wet food.
The daily ration can also be administered in several smaller meals throughout the day, to accommodate the individual preferences of the cat and to promote consistent food intake.
Vikaly is a prescription diet.
References
Finalists are chosen by a panel of industry leaders on the basis that they embody the qualities that define veterinary excellence: compassion, teamwork, innovation and a relentless commitment to animal welfare.
The finalists this year are:
Vet of the Year
Vet Nurse of the Year
Practice Support Staff of the Year
Practice of the Year
The winners will be announced at the London Vet Show on Thursday 20th.
Good luck, one and all!
Purina says it is common for dogs with gastrointestinal disturbances not to digest fat properly1, resulting in water secretion in the gut and loose stools2, production of anti-inflammatory compounds2 and altered microbiome composition 3,4.
The company says a limited fat diet can help, but some conditions, such as hyperlipidaemia, require even lower fat levels, such as found in the new EN Low Fat diet.
If you go to stand P20 and watch a short video about the new diet, you'll be entered into a draw to with prizes which include shopping vouchers, gym bags and umbrellas.
Vets from the Purina Technical Support Line will also be on the stand to answer questions about the new product.
Zoetis says AI Masses delivers fast, accurate, in-clinic screening of common lymph node and skin/subcutaneous masses in minutes, making Vetscan Imagyst the most capable veterinary AI analyser in the world.
AI Masses uses an algorithm to identify and classify common skin/subcutaneous mass and lymph node aspirates at the point of care.
At additional charge, for added diagnostic confidence, Zoetis also offers expert clinical pathologist reviews via Digital Cytology and Add-on Expert Review within hours.
Abhay Nayak, President, Global Diagnostics at Zoetis said: “By empowering veterinary teams with valuable insights into potentially cancerous cells, we are helping to reduce waiting times and alleviate stress for pet owners facing some of the most challenging moments with their beloved pets.
https://www.zoetisdiagnostics.com/uk/point-of-care
In short, it’s a system which gives clients a breakdown of the options you have recommended, with an explanation of the procedure or treatment, potentially the pros and cons, and the price.
When time permits, this allows the client to consider their options at home, on their own, with the information in front of them, taking away the pressure that sometimes comes with having to make these decisions in front of a veterinary professional.
The system works as a standalone web-based service at present, but integrations with VetIT and Lupa are in development.
Practices can configure the software with their own information about treatment and procedures, but VetConsent has also teamed up with Visiocare and Vetlexicon to provide graphically rich material to help the client understand even better.
The service costs £40 per vet per month.
Chief Veterinary Officer, Nick Lloyd MRCVS said: “We’re confident that the time-savings alone will more than cover the cost of the service, but even more importantly, it improves the service you offer clients and ensures that you’ve covered all the bases in getting informed consent.”
https://vetconsent.com
The project aims to produce evidence to help reduce the risk of musculoskeletal injury, one of the leading causes of morbidity and mortality in racehorses worldwide.
The researchers say that despite significant advances in understanding of injuries that occur in horses on a racecourse, there is currently limited information on injuries that happen during training.
The study aims to identify modifiable risk factors and inform practical, evidence-based recommendations for trainers and equine vets.
Over a three-year period, the RVC-led research team will conduct prospective cohort studies in flat and national hunt (jump) thoroughbreds in training.
The researchers will estimate the incidence of the most common types of musculoskeletal injuries in racehorses in training, including fracture and tendon and joint injuries, develop novel measures of training workload that can be used to monitor training over time, and investigate how training regimes can be optimised to reduce the risk of exercise-induced injury.
The study will also trial the use of wearable technology to establish its practical usefulness for large-scale application in measuring horses’ training workload.
Professor Kristien Verheyen, Professor of Veterinary Clinical Epidemiology at the RVC, said: “This large-scale study will fill key knowledge gaps on injury occurrence in racehorses in training.
"Its findings will directly impact racehorse welfare by identifying opportunities for intervention based on ‘best practice’ in current training regimens to reduce the likelihood of injury.”
https://www.rvc.ac.uk/research/projects/training-injury-prevention-study
The company is hosting 14 sessions over the two days, delivering over 8 hours of CPD
Speakers include Tara Ryan, CVS Chief Veterinary Officer, Laurent Garosi, Clinical Director of Vet Oracle Teleradiology, Kieran Borgeat, Specialist in Veterinary Cardiology at Bristol Vet Specialists, Emma Cooper, Head Veterinary Surgeon at Bell Equine, Alan Johnson, Regional Clinical Lead at CVS and Mark Moreton, CVS Director of Learning & Development.
Clinical topics will range from bone marrow biopsies and neurological examinations, to emergency diagnostics and perioperative analgesia.
Professional discussions will focus on clinical freedom or clinical guidance, and why career progression is more than certificates or practice ownership.
Leadership and management sessions will cover supporting new graduates and adopting the right coaching mindset.
Mark Moreton said: “Whether you're a vet, nurse, practice manager or student - there’s something here for everyone.
"CVS Learning Live is designed to help our veterinary colleagues grow, connect, and thrive.
"It reflects our ongoing mission to help every colleague reach their full potential through accessible, high-quality education and peer support.
"We encourage delegates to plan their sessions in now so that they don’t miss out.”
https://london.vetshow.com/conference-programme.
The Clinical Research Project grants support the undertaking for small-scale research projects in companion animals, with the ultimate objective of advancing understanding of the causes and/or management of a clinical disorder.
The awards include funding for:
The projects are expected to be completed by 2028.
https://bsava.com/petsavers
The CMA provisional decision was widely seen as less interventional than had been expected, largely demanding transparency over things like pricing, practice ownership and billing, which many practices had already implemented.
However, one provisional decision was that regardless of their status, all veterinary practices should inform owners that they can ask for a written prescription and explain that they may be able to have it fulfilled cheaper online.
Two of the largest online veterinary pharmacies are animed.co.uk, which is owned by CVS, and peddrugsonline, which is owned by IVC.
So in effect, the decision asked independent practices to direct their clients to competitor businesses.
What you might call a bitter pill to swallow.
In the light of the announcement, CVS issued a press release citing the "clarity" afforded by the CMA announcement and the fact that it does not think the CMA's proposed remedies will have a material impact, as factors behind its decision to seek a Main Market listing.
The company has also announced a £20m share buyback programme.
The company says the new framework is designed to help veterinary teams make prescribing decisions which balance animal welfare, public health, and environmental sustainability, the latter especially in the light of recent research which found significant levels of imidacloprid and fipronil - which are toxic to invertebrates - in waterways1,2.
The Lifestyle Parasite Risk Assessment considers the following factors before recommending treatment, including:
Alongside the new assessment, CVS has launched a training course for all staff who interact with parasiticides, so they can confidently explain the benefits of lifestyle-based prescribing.